A detailed history of Riverview Trust CO transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Riverview Trust CO holds 254 shares of VRTX stock, worth $131,251. This represents 0.11% of its overall portfolio holdings.

Number of Shares
254
Previous 194 30.93%
Holding current value
$131,251
Previous $90,000 31.11%
% of portfolio
0.11%
Previous 0.09%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$460.0 - $505.78 $27,600 - $30,346
60 Added 30.93%
254 $118,000
Q1 2024

Apr 12, 2024

BUY
$407.69 - $446.08 $79,091 - $86,539
194 New
194 $81,000
Q1 2022

Apr 21, 2022

BUY
$221.42 - $260.97 $42,955 - $50,628
194 New
194 $51,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $133B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Riverview Trust CO Portfolio

Follow Riverview Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Riverview Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Riverview Trust CO with notifications on news.